Cell Reports (Mar 2021)

Human spinal GABA neurons alleviate spasticity and improve locomotion in rats with spinal cord injury

  • ChenZi Gong,
  • Xiaolong Zheng,
  • FangLiang Guo,
  • YaNan Wang,
  • Song Zhang,
  • Jing Chen,
  • XueJiao Sun,
  • Sayed Zulfiqar Ali Shah,
  • YiFeng Zheng,
  • Xiao Li,
  • Yatao Yin,
  • Qian Li,
  • XiaoLin Huang,
  • Tiecheng Guo,
  • Xiaohua Han,
  • Su-Chun Zhang,
  • Wei Wang,
  • Hong Chen

Journal volume & issue
Vol. 34, no. 12
p. 108889

Abstract

Read online

Summary: Spinal cord injury (SCI) often results in spasticity. There is currently no effective therapy for spasticity. Here, we describe a method to efficiently differentiate human pluripotent stem cells from spinal GABA neurons. After transplantation into the injured rat spinal cord, the DREADD (designer receptors exclusively activated by designer drug)-expressing spinal progenitors differentiate into GABA neurons, mitigating spasticity-like response of the rat hindlimbs and locomotion deficits in 3 months. Administering clozapine-N-oxide, which activates the grafted GABA neurons, further alleviates spasticity-like response, suggesting an integration of grafted GABA neurons into the local neural circuit. These results highlight the therapeutic potential of the spinal GABA neurons for SCI.

Keywords